Additionally, higher levels of NR5A2 were also detected in adriamycin‐resistant breast cancer cells, and the overexpression of NR5A2 in breast cancer cells and transplanted tumors in nude mice led to an attenuation in the effects of adriamycin and cisplatin on the cancer cells.29 This evidence concerns the gene NR5A2 and breast carcinoma.